The alpha-glucosidase inhibitor miglitol increases hepatic CYP7A1 activity in association with altered short-chain fatty acid production in the gut of obese diabetic mice-Reference-Cited by-同舟云学术

The alpha-glucosidase inhibitor miglitol increases hepatic CYP7A1 activity in association with altered short-chain fatty acid production in the gut of obese diabetic mice

Published:2020-03 Issue: Volume:5 Page:100024
ISSN:2589-9368
Container-title:Metabolism Open
language:en
Short-container-title:Metabolism Open

Author:

Hamada Yoji,Goto Moritaka^ORCID,Nishimura Go,Nagasaki Hiroshi,Seino Yusuke,Kamiya Hideki,Nakamura Jiro

Funder

SKK

Publisher

Elsevier BV

Subject

General Medicine

Reference20 articles.

1. Endocrine functions of bile acids;Houten;EMBO J,2006

2. Bile acids regulate hepatic gluconeogenic genes and farnesoid X receptor via G(alpha)i-protein-coupled receptors and the AKT pathway;Cao;J Lipid Res,2010

3. The alpha-glucosidase inhibitor miglitol affects bile acid metabolism and ameliorates obesity and insulin resistance in diabetic mice;Hamada;Metabolism,2013

4. Bile acids: regulation of synthesis;Chiang;J Lipid Res,2009

5. Bile acid transporters;Dawson;J Lipid Res,2009

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bifidobacterium longumBL‐19 inhibits oxidative stress and inflammatory damage in the liver of mice with NAFLD by regulating the production of butyrate in the intestine;Food Science & Nutrition;2024-06-18

2. Phenolics from endophytic fungi as natural α-glucosidase inhibitors: A comprehensive review;Journal of Molecular Structure;2023-11

3. Miglitol, an Oral Antidiabetic Drug, Downregulates Melanogenesis in B16F10 Melanoma Cells through the PKA, MAPK, and GSK3β/β-Catenin Signaling Pathways;Molecules;2022-12-23

4. Targets of statins intervention in LDL-C metabolism: Gut microbiota;Frontiers in Cardiovascular Medicine;2022-09-08

5. Lingguizhugan Decoction Targets Intestinal Microbiota and Metabolites to Reduce Insulin Resistance in High-Fat Diet Rats;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2022-08